Nrf2 activators from Glycyrrhiza inflata and their hepatoprotective activities against CCl4-induced liver injury in mice

Y Lin, Y Kuang, K Li, S Wang, S Ji, K Chen… - Bioorganic & medicinal …, 2017 - Elsevier
Y Lin, Y Kuang, K Li, S Wang, S Ji, K Chen, W Song, X Qiao, M Ye
Bioorganic & medicinal chemistry, 2017Elsevier
Glycyrrhiza inflata (licorice) has been used to treat liver diseases for a long history. However,
the bioactive compounds are still not clear. In this work, 77 compounds, including 9 new
ones, were isolated from the EtOAc extract of the roots and rhizomes of G. inflata. The Nrf2
activation activities of all compounds were screened using ARE-luciferase reporter assay on
HepG2C8 cells. The results indicated a number of chalcones were potent Nrf2 activators,
including 11 (licochalcone A, 4.07-fold), 12 (licochalcone B, 5.17-fold), and 19 (echinatin …
Abstract
Glycyrrhiza inflata (licorice) has been used to treat liver diseases for a long history. However, the bioactive compounds are still not clear. In this work, 77 compounds, including 9 new ones, were isolated from the EtOAc extract of the roots and rhizomes of G. inflata. The Nrf2 activation activities of all compounds were screened using ARE-luciferase reporter assay on HepG2C8 cells. The results indicated a number of chalcones were potent Nrf2 activators, including 11 (licochalcone A, 4.07-fold), 12 (licochalcone B, 5.17-fold), and 19 (echinatin, 4.09-fold). Further studies indicated that 11, 12 and 19 remarkably attenuated CCl4-induced acute liver injury in mice (10 or 50 mg/kg, 7 days, ig.). These compounds could be promising hepatoprotective natural agents.
Elsevier